Delscience
Nanomedicine and Drug Delivery News
Filter     Order     Display # 
Date Item Title
Thursday, 17 April 2008 Innocoll's Gentamicin Topical new human study commences
Wednesday, 16 April 2008 Zelos and Aegis sign deal for Intravail(R) technology
Monday, 14 April 2008 Jazz launches Luvox(R) CR
Monday, 14 April 2008 Oramed starts phase 2a for oral insulin
Monday, 14 April 2008 sNDA for RISPERDAL(R) CONSTA(R)
Wednesday, 09 April 2008 Nektar terminates insulin programs
Tuesday, 08 April 2008 Iomai receives grant to develop anthrax vaccine
Tuesday, 08 April 2008 Aradigm starts trial using AERx technology
Monday, 07 April 2008 Endo to return rights to CHRONOGESIC(R)
Friday, 04 April 2008 Abraxis acquires Shimoda Biotech
Thursday, 03 April 2008 Iomai and Merck enter agreement to evaluate patch
Thursday, 03 April 2008 Indevus licenses VANTAS(R) to Orion
Wednesday, 02 April 2008 Abraxis commences phase 2 of Coroxane(TM)
Tuesday, 01 April 2008 Vivus reaches SPA agreement for Luramist(TM)
Monday, 31 March 2008 Elite Pharmaceuticals updates data on pain products
Monday, 31 March 2008 Acusphere licences HDDS(TM) to Cephalon
Monday, 31 March 2008 QLT starts phase 2 study for punctal plug drug delivery system
Monday, 31 March 2008 Teva will acquire Bentley
Thursday, 27 March 2008 Avanti launches a new drug delivery company
Thursday, 27 March 2008 IntelliPharmaCeutics completes clinical trial on ReXista(TM)
Wednesday, 26 March 2008 Alexza forms subsidiary in Singapore
Monday, 24 March 2008 Depomed starts phase 3 study of Gabapentin GR(TM)
Monday, 24 March 2008 Zogenix files for IPO
Monday, 24 March 2008 Biovail settles case with SEC
Wednesday, 19 March 2008 Abbott receives rights to Lupron Depot(R)
Wednesday, 19 March 2008 Emisphere updates data on oral B12
Wednesday, 19 March 2008 BioSante initiates third phase 3 study for LibiGel(R)
Wednesday, 19 March 2008 Alkermes restructures operations
Tuesday, 18 March 2008 Alimera and pSivida amend deal on Medidur(TM)
Tuesday, 18 March 2008 DiObex and Camurus sing license agreement
Monday, 17 March 2008 NanoBio completes phase 2 trial of NB-001
Monday, 17 March 2008 FDA reviews QLT's Aczone(TM)
Monday, 17 March 2008 Baxter presents clinical results of subcutaneous GAMMAGARD LIQUID(TM)
Thursday, 13 March 2008 Silence Therapeutics and AstraZeneca to collaborate
Thursday, 13 March 2008 Innocoll commences second phase 2 trial of surgical implant
Wednesday, 12 March 2008 Celsion starts phase 3 for ThermoDox(R)
Tuesday, 11 March 2008 Abbott receives CE Mark for 2.25 mm XIENCE(TM) V DES
Tuesday, 11 March 2008 Inovio reports data on malignant melanoma study
Tuesday, 11 March 2008 Cerner and UNM enter deal to evaluate a DPI
Monday, 10 March 2008 Halozyme presents PK data on new manufacturing process
Friday, 07 March 2008 AVANT and Celldex complete merger
Friday, 07 March 2008 Lilly terminates inhaled insulin agreement with Alkermes
Thursday, 06 March 2008 Penwest announces private placement
Thursday, 06 March 2008 NanoBio receives funding
Wednesday, 05 March 2008 Notice from NASDAQ to Hana Biosciences
Tuesday, 04 March 2008 Debio moves Debio 9902 SR forward
Monday, 03 March 2008 MicroDose and Merck & Co. sign a deal
Thursday, 28 February 2008 Not approvable letter for Lilly's Zyprexa(R) LAI
Thursday, 28 February 2008 Arriva receives financing from Nordic Biotech
Wednesday, 27 February 2008 NeurogesX reports results from phase 3 study of NGX-4010
 
<< Start < Prev 1 2 3 4 Next > End >>
Results 1 - 50 of 185


FAQ . Copyright 2007. Sitemap . Privacy policy